Below is a comprehensive list of suppliers of the AIR interventional agents required to implement the strategies described in the research we cite, and describe herein.

Some of the research studies describe the results of approved pharmaceuticals like rapamycin, metformin and Deprenyl, but utilized off label to directly address aging. Other agents emerging in the efforts to regress aging are old drugs and/or banned substances like procaine Hci, that the FDA has determined are not safe or have no medicinal value.

New biomarkers and new understanding of the meaning of these markers are providing new mechanistic insights into how old drugs have the potential of impacting the rate at which individuals age. Epigeneit markers are disclosing the path to actually regressing the biological age of the individuals incorporating these agents.

Some supplements are in a regulatory gray zone. This includes many of the organ derived peptides.

All of these aging interventions have a large and growing body of bench-top, animal and human research to support incorporating them in a highly impactful, age-regressive stratgie.

We provide below a targeted list of suppliers for all interventional agents identified in the literature. We are in no way advocating that anyone break any customs embargo or FDA regulation.

◉ Any intelligent age regression stratgie includes the involvement of your primary care physician.

If you have located a good resource, or you are a supplier willing to provide a discount to our subscribers, please share the relevant information. You can use the Contribute Content link in the footer of this page.